As of January 22, 2025, Jaguar Health (JAGX) has a market cap of $9.810 million USD. According to our data, Jaguar Health is ranked No.8871 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $9.81 M |
-17.67%
|
Dec 31, 2024 | $11.92 M |
-88.85%
|
Dec 29, 2023 | $0.11 B |
-97.69%
|
Dec 30, 2022 | $4.62 B |
-91.63%
|
Dec 31, 2021 | $55.22 B |
-57.46%
|
Dec 31, 2020 | $129.81 B |
1.75%
|
Dec 31, 2019 | $127.58 B |
-95.00%
|
Dec 31, 2018 | $2.553 T |
-89.10%
|
Dec 29, 2017 | $23.414 T |
-80.45%
|
Dec 30, 2016 | $119.744 T |
-68.18%
|
Dec 31, 2015 | $376.292 T |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Amarin Corporation
AMRN
|
$0.22 B |
0.000 M
|
Ireland
|
Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
Esperion Therapeutics
ESPR
|
$0.43 B |
-0.000 M
|
USA
|
Heron Therapeutics
HRTX
|
$0.25 B |
0.000 M
|
USA
|
Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
Market Cap | = | JAGX Stock Price | * | JAGX Shares Outstanding |
= | $0.83 | * | 11.80 M | |
= | $9.81 M |